GAM
MRNA icon

Generali Asset Management’s Moderna MRNA Stock Holding History

Generali Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-56,799
Closed -$1.68M – 501
2025
Q4 		$1.68M Sell
56,799
-2,719
-5% -$73.9K 0.03% 337
2025
Q3 		$1.54M Sell
59,518
-166
-0.3% -$4.63K 0.03% 353
2025
Q2 		$1.65M Sell
59,684
-211
-0.4% -$5.56K 0.04% 348
2025
Q1 		$1.7M Buy
+59,895
New +$2.13M 0.04% 333

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Generali Asset Management's MRNA Position: Q1 2026 in Review

Generali Asset Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 56,799 shares — an estimated $1.68M sold.

Generali Asset Management first reported a position in MRNA in Q1 2025 and held it in 4 quarters. The position peaked at $1.7M in Q1 2025. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Generali Asset Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Generali Asset Management sold 56,799 Moderna shares in Q1 2026, an estimated $1.68M.
  • Generali Asset Management first reported a position in Moderna in Q1 2025 and held it in 4 quarters.
  • Generali Asset Management's Moderna position peaked at $1.7M in Q1 2025.
  • 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Generali Asset Management's 13F filing for Q1 2026, filed 5 May 2026.